SCN2A is a gene encoding the alpha-2 subunit of the Nav1.2 sodium channel. This channel allows sodium ions to enter the cell and helps facilitate the transmission of electrical signals between cells. The effects of specific mutations in SCN2A can be ascertained by introducing a replica of the gene containing a particular mutation into cells and then measuring the electrical activities of those cells.
We are pleased to offer our mutation characterization and drug screening services for eligible pathogenic mutations within SCN2A at the current rate of $50,000 and an anticipated timeline of six months. Please contact us with interests and inquiries.